ArticleClinical and translational medicine2025

Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes.

Luis Zafra-Puerta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.